Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/587"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1586"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_traceable_Drug_Label_Statement
?:content	"CYP3A4 Inhibitors: In vitro studies indicate that venlafaxine is likely metabolized to a minor, less active metabolite, N-desmethylvenlafaxine, by CYP3A4. Because CYP3A4 is typically a minor pathway relative to CYP2D6 in the metabolism of venlafaxine, the potential for a clinically significant drug interaction between drugs that inhibit CYP3A4-mediated metabolism and venlafaxine is small."
dc:creator	"boycer"
dc:date	"06/09/2009 19:52:03"
rdfs:seeAlso	?:cf2d9bee-f8e3-477a-e4b4-f0e82657b7d2

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ venlafaxine_has_metabolite_N-desmethylvenlafaxine, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1586 }

Context graph